Continuation and maintenance pharmacotherapy in geriatric depression: an open-trial comparison of paroxetine and nortriptyline in patients older than 70 years.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Clinical Psychiatry

• Publication date

  1999-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 10513854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.

  1999cited by this paper
• Treatment of 70(+)-year-olds with recurrent major depression. Excellent short-term but brittle long-term response.

  1999cited by this paper
• A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome.

  1999cited by this paper
• Diagnosis and treatment of depression in late life. Consensus statement update.

  1997cited by this paper
• Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study.

  1997cited by this paper
• Cost of community care for older people

  1997cited by this paper
• Diagnosis and Treatment of Depression in Late Life: Consensus Statement Update

  1997cited by this paper
• Global health statistics: a compendium of incidence prevalence and mortality estimates for over 200 conditions.

  1996cited by this paper
• Rationalizing antidepressants for elderly people

  1995cited by this paper
• Depression and 18-month prognosis after myocardial infarction.

  1995cited by this paper
• Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference

  1994cited by this paper
• Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression

  1993cited by this paper
• A Double‐Blind Study of Paroxetine Compared With Fluoxetine in Geriatric Patients With Major Depression

  1993cited by this paper
• Depression following myocardial infarction. Impact on 6-month survival.

  1993cited by this paper
• Depression and increased risk of mortality in the nursing home patient.

  1993cited by this paper
• How long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. Old Age Depression Interest Group.

  1993cited by this paper
• Optimal dose regimen for paroxetine.

  1992cited by this paper
• Paroxetine in the Treatment of Elderly Depressed Patients in General Practice: A Double‐Blind Comparison with Amitriptyline

  1992cited by this paper
• The safety profile of paroxetine.

  1992cited by this paper
• Medication compliance in the elderly.

  1989cited by this paper
• U.S. NATIONAL CENTER FOR HEALTH STATISTICS

  1967cited by this paper

• Model-informed precision dosing of paroxetine to optimize individualized therapy in patients with mental disorders.

  2026cites this paper
• Defining the Therapeutic Reference Range and Optimizing a High-Dose Discontinuation Strategy for Paroxetine Based on TDM and Population Pharmacokinetics.

  2025cites this paper
• Drugs to Treat Depression.

  2020cites this paper
• Adverse Effects of Pharmacological Treatments of Major Depression in Older Adults

  2019cites this paper
• Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

  2015cites this paper
• Depression : can we predict who will relapse?

  2014cites this paper
• Major Depressive Disorder in Older Adults: Benefits and Hazards of Prolonged Treatment

  2014cites this paper
• Antidepressant Treatment of Geriatric Depression

  2011cites this paper
• Legemiddelbehandling hos eldre innlagt for psykisk lidelse

  2009cites this paper
• The Pursuit of Happiness: Management of Depression in the Elderly A review for the practicing physician

  2008cites this paper
• Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines

  2008cites this paper
• Determination of Paroxetine in Plasma by Liquid Chromatography Coupled to Tandem Mass Spectrometry for Pharmacokinetic and Bio equivalence Studies

  2007cites this paper
• Long term studies of depression: what is relevant for the physician?

  2006cites this paper
• Modeling and Simulation Approach to Characterize the Magnitude and Consistency of Drug Exposure using Sparse Concentration Sampling

  2006cites this paper
• Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling.

  2006cites this paper
• Extended-release venlafaxine in relapse prevention for patients with major depressive disorder.

  2004cites this paper
• Achieving Long-Term Optimal Outcomes in Geriatric Depression and Anxiety

  2003cites this paper
• Efficacy of controlled-release paroxetine in the treatment of late-life depression.

  2003cites this paper
• The apolipoprotein E epsilon4 allele and antidepressant efficacy in cognitively intact elderly depressed patients.

  2003cites this paper
• A Self-Controlled, Naturalistic Study of Selective Serotonin Reuptake Inhibitors versus Tricyclic Antidepressants

  2003cites this paper
• The apolipoprotein E ε4 allele and antidepressant efficacy in cognitively intact elderly depressed patients

  2003cites this paper
• Pharmacotherapy of Geriatric Depression

  2002cites this paper
• Drug and ECT treatment of depression in the elderly, 1996-2001: a literature review.

  2002cites this paper
• Late-Life Depression: Rationalizing Pharmacological Treatment Options

  2002cites this paper
• Factors affecting the use and selection of antidepressants in the elderly

  2002cites this paper
• Type II error and antidepressants.

  2001cites this paper
• Paroxetin-Augmentation mit Risperidon bei therapieresistenter Depression

  2001cites this paper
• Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well.

  2001cites this paper
• [Paroxetine augmentation with risperidone in therapy-resistant depression].

  2001cites this paper
• Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients.

  2000cites this paper